These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8436073)

  • 1. [Ergotamine-induced heart valve fibrosis].
    Faber L
    Dtsch Med Wochenschr; 1993 Feb; 118(6):205. PubMed ID: 8436073
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ergotamine-induced heart valve fibrosis and coronary microangiopathy?].
    Creutzig A
    Dtsch Med Wochenschr; 1992 Nov; 117(45):1736. PubMed ID: 1425287
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiac surgery for ergotamine-induced multivalvular heart disease.
    Lazopoulos G; Papaioannou G; Kantartzis M
    Thorac Cardiovasc Surg; 2013 Aug; 61(5):435-7. PubMed ID: 23475795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Images in clinical medicine. Four artificial heart valves.
    Bijl M; van den Brink RB
    N Engl J Med; 2005 Aug; 353(7):712. PubMed ID: 16107624
    [No Abstract]   [Full Text] [Related]  

  • 5. [Valvular heart disease associated with ergotamine].
    Martínez Quintana E; Llorens León R; Redondo Martínez E; Nieto Lago V; Jiménez Cabrera F; Gross Kastanovitz E
    Rev Esp Cardiol; 2005 Jan; 58(1):97-9. PubMed ID: 15680136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fibrosis and fusion of the heart valve].
    Ohkawa S
    Kokyu To Junkan; 1993 Mar; 41(3):201-7. PubMed ID: 8469824
    [No Abstract]   [Full Text] [Related]  

  • 7. Mitral, aortic and tricuspid valvular heart disease associated with ergotamine therapy for migraine.
    Wilke A; Hesse H; Hufnagel G; Maisch B
    Eur Heart J; 1997 Apr; 18(4):701. PubMed ID: 9129909
    [No Abstract]   [Full Text] [Related]  

  • 8. Ergotamine and nicergoline - facts and myths.
    Zajdel P; Bednarski M; Sapa J; Nowak G
    Pharmacol Rep; 2015 Apr; 67(2):360-3. PubMed ID: 25712664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced valvular heart disease: an update.
    Andrejak M; Tribouilloy C
    Arch Cardiovasc Dis; 2013 May; 106(5):333-9. PubMed ID: 23769407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pergolide treatment and cardiac valve pathology: the continuing saga of ergotamine-induced fibrosis].
    Montastruc JL; Pathak A; Bagheri H
    Rev Neurol (Paris); 2004 Jan; 160(1):19-21. PubMed ID: 14978390
    [No Abstract]   [Full Text] [Related]  

  • 11. Anorectic therapy and valvular heart disease: a reappraisal.
    Silvestry FE; St John Sutton M
    Eur Heart J; 1999 Jul; 20(13):917-20. PubMed ID: 10361039
    [No Abstract]   [Full Text] [Related]  

  • 12. [The link between drug use and heart valve disease].
    Grinberg M; Halpern A; Rossi EG; Leite CC; Sbano JC
    Arq Bras Cardiol; 1998 Mar; 70(3):181-3. PubMed ID: 9674180
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac valvulopathy.
    Schachter M
    Hosp Med; 2005 Apr; 66(4):228. PubMed ID: 15889872
    [No Abstract]   [Full Text] [Related]  

  • 14. Ergotamine, methysergide, and carcinoid-induced endocardial lesions.
    Bates HR
    Arch Pathol Lab Med; 1990 Jun; 114(6):560. PubMed ID: 2346357
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental heart valve endocardiosis in dogs induced by ACTH and DOC].
    Schneider P; Ernst E; Trautwein G; Kersten U
    Endokrinologie; 1973 Oct; 62(2):202-17. PubMed ID: 4360378
    [No Abstract]   [Full Text] [Related]  

  • 16. Progenitor cells and valve degeneration.
    Skowasch D; Nickenig G; Bauriedel G
    Circ Res; 2006 May; 98(10):e71. PubMed ID: 16728662
    [No Abstract]   [Full Text] [Related]  

  • 17. [Myxoid dysplasia of the heart valves (author's transl)].
    Kapetanović S; Kapetanović J
    Lijec Vjesn; 1980 Nov; 102(11):613-8. PubMed ID: 7278483
    [No Abstract]   [Full Text] [Related]  

  • 18. [Valvular heart disease in adults: forward].
    Vahanian A
    Rev Prat; 2000 Oct; 50(15):1640-1. PubMed ID: 11116602
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pergolide use and heart valve fibrosis. Yearly control in patients with Parkinson disease who use pergolide].
    van Laar T; Berendse H; Bloem BR; Boon AJ; van Hilten JJ; Hovestadt A; de Koning-Tijssen MA; Nijssen PC; Weber WE
    Ned Tijdschr Geneeskd; 2009 Jan; 153(3):87-90. PubMed ID: 19235345
    [No Abstract]   [Full Text] [Related]  

  • 20. Systems and diseases. The heart, Part Seven.
    Linden B
    Nurs Times; 2000 Jan 27-Feb 2; 96(4):49-52. PubMed ID: 11188657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.